09:05     CHANGCHUNDAXING<08067> -Announcement & Resumption of Trading        

                                                                              
    The Stock Exchange of Hong Kong Limited takes no                          
    responsibility for the contents of this announcement,                     
    makes no representation as to its accuracy or                             
    completeness and expressly disclaims any liability                        
    whatsoever for any loss howsoever arising from or in                      
    reliance upon the whole or any part of the contents                       
    of this announcement.                                                     
                                                                              
    CHANGCHUN DA XING PHARMACEUTICAL COMPANY LIMITED*                         
    (a joint stock limited company incorporated in the                        
    People's Republic of China)                                               
                                                                              
    (Stock code: 8067)                                                        
                                                                              
    APPOINTMENT OF DIRECTORS                                                  
    AND                                                                       
    ADJOURNMENT OF 2005 ANNUAL GENERAL MEETING                                
    AND                                                                       
    RESUMPTION OF TRADE                                                       
                                                                              
    The Board wishes to announce further information in                       
    respect of the appointment of Directors and                               
    adjournment of the 2005 Annual General Meeting of                         
    Changchun Da Xing Pharmaceutical Company Limited.                         
                                                                              
    Trading in the shares of the Company on the Stock                         
    Exchange was suspended at the requested of the Company                    
    with effect from 9:30 a.m. on 3 May 2005 pending for                      
    release of this announcement. Application has been                        
    made to the Stock Exchange for resumption of trading                      
    in the shares of the Company on the Stock Exchange                        
    with effect from 9:30 a.m. on 4 May 2005.                                 
                                                                              
    By order of the Board                                                     
    Changchun Da Xing Pharmaceutical Company Limited                          
    Feng Zhen Wen                                                             
    Chairman                                                                  
                                                                              
    Changchun, the PRC, 3 May 2005                                            
                                                                              
    As at the date of this announcement the Board                             
    comprises five executive directors, being Feng Zhen                       
    Wen, Yu Cheng Kun, Li Xiu Jie, Guo Bin and Lu Yin Hua;                    
    a non-executive director, Lu De Yi; and three                             
    independent non-executive directors, being Yang Shi                       
    Jie, Sun Xiao Bo and Zhang Zhong Sheng.                                   
                                                                              
    This announcement, for which the directors of                             
    Changchun Da Xing Pharmaceutical Company Limited (the                     
    "Directors") collectively and individually accept                         
    full responsibility, includes particulars given in                        
    compliance with the Rules Governing the Listing of                        
    Securities on the Growth Enterprise Market of The                         
    Stock Exchange of Hong Kong Limited for the purpose                       
    of giving information with regard to Changchun Da Xing                    
    Pharmaceutical Company Limited. The Directors,                            
    having made all reasonable enquiries, confirm that,                       
    to the best of their knowledge and belief: (1) the                        
    information contained in this announcement is                             
    accurate and complete in all material respects and                        
    not misleading; (2) there are no other matters the                        
    omission of which would make any statement in this                        
    announcement misleading; and (3) all opinions                             
    expressed in this announcement have been arrived at                       
    after due and careful consideration and are founded                       
    on bases and assumptions that are fair and reasonable.                    
                                                                              
    The above announcement is a summary only. For the full                    
    version of this announcement, please refer to the                         
    'Latest Company Announcements' page on the GEM                            
    website at www.hkgem.com.                                                 
                                                                              
    * For indentification only